| Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesis T McKerrell, N Park, T Moreno, CS Grove, H Ponstingl, J Stephens, ... Cell reports 10 (8), 1239-1245, 2015 | 527 | 2015 |
| Unraveling the cellular origin and clinical prognostic markers of infant B-cell acute lymphoblastic leukemia using genome-wide analysis A Agraz-Doblas, C Bueno, R Bashford-Rogers, A Roy, P Schneider, ... haematologica 104 (6), 1176, 2019 | 88 | 2019 |
| Development and validation of a comprehensive genomic diagnostic tool for myeloid malignancies T McKerrell, T Moreno, H Ponstingl, N Bolli, JML Dias, G Tischler, ... Blood, The Journal of the American Society of Hematology 128 (1), e1-e9, 2016 | 67 | 2016 |
| JAK2 V617F hematopoietic clones are present several years prior to MPN diagnosis and follow different expansion kinetics T McKerrell, N Park, J Chi, G Collord, T Moreno, H Ponstingl, J Dias, ... Blood Advances 1 (14), 968-971, 2017 | 55 | 2017 |
| Detailed molecular characterisation of acute myeloid leukaemia with a normal karyotype using targeted DNA capture N Conte, I Varela, C Grove, N Manes, K Yusa, T Moreno, ... Leukemia 27 (9), 1820-1825, 2013 | 34 | 2013 |
| ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to chemotherapy in lung cancer T Moreno, B Monterde, L González-Silva, I Betancor-Fernández, C Revilla, ... Oncogene 40 (16), 2923-2935, 2021 | 30 | 2021 |
| The 5-hydroxymethylcytosine landscape of prostate cancer M Sjöström, SG Zhao, S Levy, M Zhang, Y Ning, R Shrestha, A Lundberg, ... Cancer research 82 (21), 3888-3902, 2022 | 23 | 2022 |
| Understanding Society Scientific G T McKerrell, N Park, T Moreno, CS Grove, H Ponstingl, J Stephens, ... Crawley C, Craig J, Scott MA, Hodkinson C, Baxter J, Rad R, Forsyth DR …, 2015 | 23 | 2015 |
| Colorectal adenomas contain multiple somatic mutations that do not coincide with synchronous adenocarcinoma specimens JP Vaque, N Martinez, I Varela, F Fernandez, M Mayorga, S Derdak, ... PLoS One 10 (3), e0119946, 2015 | 16 | 2015 |
| Human Brain Microvascular Endothelial Cells Exposure to SARS-CoV-2 Leads to Inflammatory Activation through NF-κB Non-Canonical Pathway and Mitochondrial Remodeling CS Motta, S Torices, BG da Rosa, AC Marcos, L Alvarez-Rosa, M Siqueira, ... Viruses 15 (3), 745, 2023 | 12 | 2023 |
| The genomic and epigenomic landscape of double-negative metastatic prostate cancer A Lundberg, M Zhang, R Aggarwal, H Li, L Zhang, A Foye, M Sjöström, ... Cancer Research, CAN-23-0593, 2023 | 7 | 2023 |
| SARS-CoV-2 infection of human brain microvascular endothelial cells leads to inflammatory activation through NF-κB non-canonical pathway and mitochondrial remodeling S Torices, C Motta, B da Rosa, A Marcos, L Alvarez-Rosa, M Siqueira, ... Research Square, 2022 | 7 | 2022 |
| Individualized strategies to target specific mechanisms of disease in malignant melanoma patients displaying unique mutational signatures S Curiel-Olmo, A García-Castaño, R Vidal, H Pisonero, I Varela, ... Oncotarget 6 (28), 25452, 2015 | 5 | 2015 |
| ARID2 deficiency promotes tumor progression and is associated with higher sensitivity to PARP inhibition in lung cancer T Moreno, L González-Silva, B Monterde, I Betancor-Fernández, C Revilla, ... bioRxiv, 2020.01. 10.898726, 2020 | 3 | 2020 |
| Molecular characterization of the role of chromatin remodeling complexes in tumor progression TM Rodríguez Universidad de Cantabria, 2017 | 2 | 2017 |
| Why ARNT Prostate Tumors Responding to Enzalutamide? M Zhang, T Moreno-Rodriguez, DA Quigley Cancer Discovery 12 (9), 2017-2019, 2022 | 1 | 2022 |
| PO-376 SWI/SNF alterations as markers for prognosis and specific treatments in human cancer T Moreno, L Gonzalez-Silva, C Revilla, B Monterde, A Agraz-Doblas, ... ESMO Open 3, A169, 2018 | 1 | 2018 |
| Abstract LB196: An atlas of accessible chromatin in advanced prostate cancer R Shrestha, LN Chesner, M Zhang, S Zhou, A Foye, A Lundberg, ... Cancer Research 84 (7_Supplement), LB196-LB196, 2024 | | 2024 |
| Somatostatin receptor 1 (SSTR1) expression as a potential predictive biomarker for response to androgen receptor signaling inhibitor (ARSI) therapy in metastatic … X Zhu, DJ Vis, M Sjöström, R Shrestha, J Kneppers, T Severson, Y Zhu, ... Journal of Clinical Oncology 42 (4_suppl), 180-180, 2024 | | 2024 |
| Association of a prostate cancer gastrointestinal transcriptional phenotype as found in clinical mCRPC samples with response to AR-targeted therapy. A Subramanian, M Zhang, MN Sharifi, T Moreno Rodriguez, E Feng, ... Journal of Clinical Oncology 42 (4_suppl), 203-203, 2024 | | 2024 |
